These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 8710201)
1. Neuromodulation of frontal and temporal cortex by intravenous d-fenfluramine: an [15O]H2O PET study in humans. Meyer JH; Kapur S; Wilson AA; DaSilva JN; Houle S; Brown GM Neurosci Lett; 1996 Mar; 207(1):25-8. PubMed ID: 8710201 [TBL] [Abstract][Full Text] [Related]
2. No effect of depression on [(15)O]H2O PET response to intravenous d-fenfluramine. Meyer JH; Kennedy S; Brown GM Am J Psychiatry; 1998 Sep; 155(9):1241-6. PubMed ID: 9734549 [TBL] [Abstract][Full Text] [Related]
3. Increased left posterior parietal-temporal cortex activation after D-fenfluramine in women with panic disorder. Meyer JH; Swinson R; Kennedy SH; Houle S; Brown GM Psychiatry Res; 2000 May; 98(3):133-43. PubMed ID: 10821996 [TBL] [Abstract][Full Text] [Related]
4. Quantitative PET analysis of regional cerebral blood flow and glucose and oxygen metabolism in response to fenfluramine in living porcine brain. Smith DF; Poulsen PH; Ishizu K; Sakoh M; Hansen SB; Gee AD; Bender D; Gjedde A J Neurosci Methods; 1998 Dec; 86(1):17-23. PubMed ID: 9894782 [TBL] [Abstract][Full Text] [Related]
5. Gender differences in a fenfluramine-activated FDG PET study of borderline personality disorder. Soloff PH; Meltzer CC; Becker C; Greer PJ; Constantine D Psychiatry Res; 2005 Apr; 138(3):183-95. PubMed ID: 15854787 [TBL] [Abstract][Full Text] [Related]
6. Positron emission tomographic imaging of serotonin activation effects on prefrontal cortex in healthy volunteers. Mann JJ; Malone KM; Diehl DJ; Perel J; Nichols TE; Mintun MA J Cereb Blood Flow Metab; 1996 May; 16(3):418-26. PubMed ID: 8621746 [TBL] [Abstract][Full Text] [Related]
7. Modulation of cortical neuronal activity by a serotonergic agent: a PET study in humans. Kapur S; Meyer J; Wilson AA; Houle S; Brown GM Brain Res; 1994 May; 646(2):292-4. PubMed ID: 8069675 [TBL] [Abstract][Full Text] [Related]
8. Regional cerebral cortical activation in monoamine oxidase A-deficient mice: differential effects of chronic versus acute elevations in serotonin and norepinephrine. Holschneider DP; Scremin OU; Huynh L; Chen K; Seif I; Shih JC Neuroscience; 2000; 101(4):869-77. PubMed ID: 11113335 [TBL] [Abstract][Full Text] [Related]
9. Reduced prolactin and cortisol responses to d-fenfluramine in depressed compared to healthy matched control subjects. Cleare AJ; Murray RM; O'Keane V Neuropsychopharmacology; 1996 May; 14(5):349-54. PubMed ID: 8703303 [TBL] [Abstract][Full Text] [Related]
10. Demonstration in vivo of reduced serotonin responsivity in the brain of untreated depressed patients. Mann JJ; Malone KM; Diehl DJ; Perel J; Cooper TB; Mintun MA Am J Psychiatry; 1996 Feb; 153(2):174-82. PubMed ID: 8561196 [TBL] [Abstract][Full Text] [Related]
11. Microdialysis monitoring of variations in extracellular levels of serotonin, GABA and excitatory amino acids in the frontal cortex of awake rats in response to a single peripheral or central administration of dexfenfluramine. Rocher C; Bert L; Robert F; Trouvin JH; Renaud B; Jacquot C; Gardier AM Brain Res; 1996 Oct; 737(1-2):221-30. PubMed ID: 8930369 [TBL] [Abstract][Full Text] [Related]
12. Heterogeneity of neocortical cerebral blood flow deficits in dementia of the Alzheimer type: a [99mTc]-d,l-HMPAO SPECT study. Waldemar G; Bruhn P; Kristensen M; Johnsen A; Paulson OB; Lassen NA J Neurol Neurosurg Psychiatry; 1994 Mar; 57(3):285-95. PubMed ID: 8158175 [TBL] [Abstract][Full Text] [Related]
13. Confirmation of fenfluramine effect on 5-HT(1B) receptor binding of [(11)C]AZ10419369 using an equilibrium approach. Finnema SJ; Varrone A; Hwang TJ; Halldin C; Farde L J Cereb Blood Flow Metab; 2012 Apr; 32(4):685-95. PubMed ID: 22167236 [TBL] [Abstract][Full Text] [Related]
14. d,l-fenfluramine response in impulsive personality disorder assessed with [18F]fluorodeoxyglucose positron emission tomography. Siever LJ; Buchsbaum MS; New AS; Spiegel-Cohen J; Wei T; Hazlett EA; Sevin E; Nunn M; Mitropoulou V Neuropsychopharmacology; 1999 May; 20(5):413-23. PubMed ID: 10192822 [TBL] [Abstract][Full Text] [Related]
15. PET neuroimaging of clomipramine challenge in humans: focus on the thalamus. Smith DF; Geday J Brain Res; 2001 Feb; 892(1):193-7. PubMed ID: 11172763 [TBL] [Abstract][Full Text] [Related]
16. Fenfluramine Reduces [11C]Cimbi-36 Binding to the 5-HT2A Receptor in the Nonhuman Primate Brain. Yang KC; Stepanov V; Martinsson S; Ettrup A; Takano A; Knudsen GM; Halldin C; Farde L; Finnema SJ Int J Neuropsychopharmacol; 2017 Sep; 20(9):683-691. PubMed ID: 28911007 [TBL] [Abstract][Full Text] [Related]